ENvue Medical shares surge 20.89% after-hours after appointing David Johnson as new chairman.

ENvue Medical surged 20.89% in after-hours trading following the announcement of David Johnson’s appointment as Chairman of the Board. The change, effective February 2, 2026, introduced a new independent leader with a $10,000 monthly compensation structure, potentially signaling governance improvements or strategic realignment. While details about Johnson’s background or prior experience were not disclosed in the SEC filing, the market may have interpreted the leadership shift as a positive catalyst for operational or financial restructuring. The second news event, a generic Yahoo Finance link error, held no material relevance to the stock’s movement.